The Application Value of Serum NGAL in the Early Renal Damage and Risk Stratification in Patients with Essential Hypertension

The Application Value of Serum NGAL in the Early Renal Damage and Risk Stratification in Patients with Essential Hypertension

PENG Ling, YANG Yuwei, FENG Jiafu

PDF(1096 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1096 KB)

Labeled Immunoassays and Clinical Medicine ›› 2021, Vol. 28 ›› Issue (3) : 452-456. DOI: 10.11748/bjmy.issn.1006-1703.2021.03.019

Clinical Investigation

The Application Value of Serum NGAL in the Early Renal Damage and Risk Stratification in Patients with Essential Hypertension

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 28(3): 452-456 https://doi.org/10.11748/bjmy.issn.1006-1703.2021.03.019

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1096 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉